These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3966648)

  • 41. Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertension.
    Arner P; Wade A; Engfeldt P; Mouren M; Stepniewski JP; Sultan E; Bryce T; Lenfant B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S44-9. PubMed ID: 7527101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine.
    Hogue CW; Ward JM; Itani MS; Martyn JA
    J Appl Physiol (1985); 1992 Apr; 72(4):1326-31. PubMed ID: 1592722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered d-tubocurarine disposition during cardiopulmonary bypass surgery.
    Walker JS; Shanks CA; Brown KF
    Clin Pharmacol Ther; 1984 May; 35(5):686-94. PubMed ID: 6713781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular and neuromuscular responses to high-dose pancuronium-metocurine in pediatric burned and reconstructive patients.
    Hagen J; Martyn J; Szyfelbein SK; Goudsouzian NG
    Anesth Analg; 1986 Dec; 65(12):1340-4. PubMed ID: 3777466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metocurine requirements and plasma concentrations in burned paediatric patients.
    Martyn JA; Goudsouzian NG; Matteo RS; Liu LM; Szyfelbein SK; Kaplan RF
    Br J Anaesth; 1983 Apr; 55(4):263-8. PubMed ID: 6220728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative haemodynamic effects of tubocurarine and metocurine in the dog.
    Antonio RP; Philbin DM; Savarese JJ
    Br J Anaesth; 1979 Nov; 51(11):1007-10. PubMed ID: 518800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of tubocurarine administered by combined i.v. bolus and infusion.
    Ramzan MI; Shanks CA; Triggs EJ
    Br J Anaesth; 1980 Sep; 52(9):893-9. PubMed ID: 7437228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Defasciculation" with metocurine prevents succinylcholine-induced increases in intracranial pressure.
    Stirt JA; Grosslight KR; Bedford RF; Vollmer D
    Anesthesiology; 1987 Jul; 67(1):50-3. PubMed ID: 3605735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metocurine pharmacokinetics and pharmacodynamics in goats.
    Antognini JF; Wood R; Gronert GA
    J Vet Pharmacol Ther; 1995 Dec; 18(6):464-7. PubMed ID: 8789701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allometry of pharmacokinetics and pharmacodynamics of the muscle relaxant metocurine in mammals.
    Gronert GA; Fung DL; Jones JH; Shafer SL; Hildebrand SV; Disbrow EA
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R85-91. PubMed ID: 7840343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deep sedation and mechanical ventilation without paralysis for 3 weeks in normal beagles: exaggerated resistance to metocurine in gastrocnemius muscle.
    Gronert GA; Fung DL; Haskins SC; Steffey EP
    Anesthesiology; 1999 Jun; 90(6):1741-5. PubMed ID: 10360874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dose-effect relationship of metocurine: the integrated electromyogram of the first dorsal interosseous muscle and the mechanomyogram of the adductor pollicis compared.
    Kopman AF
    Anesthesiology; 1988 Apr; 68(4):604-7. PubMed ID: 3354898
    [No Abstract]   [Full Text] [Related]  

  • 53. [Age as a factor in dose-response relationship of drugs].
    Gundert-Remy U
    Z Gerontol Geriatr; 1995; 28(6):408-14. PubMed ID: 8581759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antagonistic effect of dibutyryl cyclic AMP on the action of d-tubocurarine].
    Hashimoto Y; Irimada T; Nakazawa K; Sato D; Iwatsuki N; Shima T
    Masui; 1985 Oct; 34(10):1316-20. PubMed ID: 3005683
    [No Abstract]   [Full Text] [Related]  

  • 55. Dosage-schedule independence of d-tubocurarine pharmacokinetics and pharmacodynamics, and recovery of neuromuscular function.
    Ham J; Miller RD; Sheiner LB; Matteo RS
    Anesthesiology; 1979 Jun; 50(6):528-33. PubMed ID: 453578
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion.
    Matteo RS; Nishitateno K; Pua EK; Spector S
    Anesthesiology; 1980 Apr; 52(4):335-8. PubMed ID: 6767421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamics of tubocurarine in humans.
    Wingard LB; Cook DR
    Br J Anaesth; 1976 Sep; 48(9):839-45. PubMed ID: 183799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreasing enflurane concentrations and d-tubocurarine neuromuscular blockade.
    Gencarelli PJ; Miller RD; Eger EI; Newfield P
    Anesthesiology; 1982 Mar; 56(3):192-4. PubMed ID: 7059028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine receptors: structure-activity relationship of d-tubocurarine analogues.
    Nelson SH; Steinsland OS
    Eur J Pharmacol; 1985 Jan; 108(2):209-12. PubMed ID: 3979441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated plasma binding cannot account for the burn-related d-tubocurarine hyposensitivity.
    Leibel WS; Martyn JA; Szyfelbein SK; Miller KW
    Anesthesiology; 1981 May; 54(5):378-82. PubMed ID: 7224206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.